NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+80.6%
5Y CAGR+15.2%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

3Y CAGR
+80.6%/yr
Annual compound
5Y CAGR
+15.2%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202574.23%
202414.55%
2023-71.38%
202212.59%
2021-151.16%
202036.52%
2019-90.83%
2018-34.13%
2017-9888.03%
201630.18%